COVID-19 VaccinE Response in Rheumatology Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
- Status
- RECRUITING
- Phase
- N/A
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
MBG453 in Lower Risk MDS
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
- Status
- COMPLETED
- Phase
- PHASE3
BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation
- Status
- COMPLETED
- Phase
- N/A
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Brain Changes in Psoriasis After Secukinumab Treatment
- Status
- COMPLETED
- Phase
- PHASE4
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
MicroRNA Profile and Erenumab Treatment
- Status
- COMPLETED
- Phase
- NA
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)
- Status
- COMPLETED
- Phase
- PHASE4
Xolair Interventional Study in ASD Patients With Comorbid Atopy
- Status
- WITHDRAWN
- Phase
- PHASE1
Canakinumab in Patients With COVID-19 and Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3